Nutex Health Inc (NUTX)

$6.82

+0.1

(+1.41%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $6.73
    $7.13
    $6.82
    downward going graph

    1.32%

    Downside

    Day's Volatility :5.61%

    Upside

    4.35%

    downward going graph
  • $4.16
    $63.75
    $6.82
    downward going graph

    39.0%

    Downside

    52 Weeks Volatility :93.47%

    Upside

    89.3%

    downward going graph

Returns

PeriodNutex Health IncSector (Health Care)Index (Russel 2000)
3 Months
-1.15%
6.4%
0.0%
6 Months
-75.78%
6.0%
0.0%
1 Year
-88.84%
8.5%
0.0%
3 Years
-99.89%
14.6%
-20.8%

Highlights

Market Capitalization
33.4M
Book Value
$12.68
Earnings Per Share (EPS)
6.0
PE Ratio
1.12
Wall Street Target Price
30.0
Profit Margin
-15.85%
Operating Margin TTM
2.15%
Return On Assets TTM
0.66%
Return On Equity TTM
-39.09%
Revenue TTM
258.8M
Revenue Per Share TTM
57.05
Quarterly Revenue Growth YOY
19.7%
Gross Profit TTM
36.3M
EBITDA
12.4M
Diluted Eps TTM
6.0
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.87
EPS Estimate Next Year
-0.18
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Nutex Health Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 339.88%

Current $6.82
Target $30.00

Company Financials

FY18Y/Y Change
Revenue
91.4K
↑ 70.32%
Net Income
-2.8M
↓ 583.5%
Net Profit Margin
-3.1K%
↓ 4164.94%
FY19Y/Y Change
Revenue
97.1M
↑ 106120.79%
Net Income
16.5M
↓ 685.72%
Net Profit Margin
16.98%
↑ 3096.93%
FY20Y/Y Change
Revenue
273.4M
↑ 181.71%
Net Income
106.0M
↑ 542.89%
Net Profit Margin
38.76%
↑ 21.78%
FY21Y/Y Change
Revenue
331.5M
↑ 21.25%
Net Income
132.6M
↑ 25.12%
Net Profit Margin
39.99%
↑ 1.23%
FY22Y/Y Change
Revenue
219.3M
↓ 33.85%
Net Income
-432.7M
↓ 426.37%
Net Profit Margin
-197.33%
↓ 237.32%
FY23Y/Y Change
Revenue
247.6M
↑ 12.93%
Net Income
-45.8M
↓ 89.42%
Net Profit Margin
-18.49%
↑ 178.84%
Q4 FY22Q/Q Change
Revenue
53.7M
↑ 89.2%
Net Income
-10.7M
↓ 97.54%
Net Profit Margin
-19.84%
↑ 1505.92%
Q1 FY23Q/Q Change
Revenue
56.3M
↑ 4.85%
Net Income
-5.1M
↓ 51.71%
Net Profit Margin
-9.14%
↑ 10.7%
Q2 FY23Q/Q Change
Revenue
58.9M
↑ 4.61%
Net Income
-3.5M
↓ 32.41%
Net Profit Margin
-5.9%
↑ 3.24%
Q3 FY23Q/Q Change
Revenue
62.7M
↑ 6.45%
Net Income
-5.5M
↑ 59.31%
Net Profit Margin
-8.84%
↓ 2.94%
Q4 FY23Q/Q Change
Revenue
69.7M
↑ 11.07%
Net Income
-31.6M
↑ 470.47%
Net Profit Margin
-45.38%
↓ 36.54%
Q1 FY24Q/Q Change
Revenue
67.5M
↓ 3.18%
Net Income
-364.1K
↓ 98.85%
Net Profit Margin
-0.54%
↑ 44.84%
FY18Y/Y Change
Total Assets
2.6M
↓ 21.35%
Total Liabilities
1.4M
↑ 44.35%
FY19Y/Y Change
Total Assets
179.2M
↑ 6749.92%
Total Liabilities
128.4M
↑ 9166.97%
FY20Y/Y Change
Total Assets
308.6M
↑ 72.16%
Total Liabilities
161.2M
↑ 25.55%
FY21Y/Y Change
Total Assets
394.7M
↑ 27.9%
Total Liabilities
203.1M
↑ 25.98%
FY22Y/Y Change
Total Assets
431.8M
↑ 9.4%
Total Liabilities
311.4M
↑ 53.36%
FY23Y/Y Change
Total Assets
398.2M
↓ 7.76%
Total Liabilities
319.1M
↑ 2.48%
Q4 FY22Q/Q Change
Total Assets
431.8M
↓ 0.64%
Total Liabilities
311.4M
↑ 3.12%
Q1 FY23Q/Q Change
Total Assets
430.1M
↓ 0.38%
Total Liabilities
320.6M
↑ 2.93%
Q2 FY23Q/Q Change
Total Assets
436.2M
↑ 1.43%
Total Liabilities
328.0M
↑ 2.32%
Q3 FY23Q/Q Change
Total Assets
479.6M
↑ 9.95%
Total Liabilities
374.7M
↑ 14.24%
Q4 FY23Q/Q Change
Total Assets
398.2M
↓ 16.97%
Total Liabilities
319.1M
↓ 14.83%
Q1 FY24Q/Q Change
Total Assets
404.3M
↑ 1.52%
Total Liabilities
324.3M
↑ 1.61%
FY19Y/Y Change
Operating Cash Flow
12.1M
↓ 2625.71%
Investing Cash Flow
-31.2M
-
Financing Cash Flow
21.7M
↑ 2981.78%
FY20Y/Y Change
Operating Cash Flow
81.3M
↑ 570.24%
Investing Cash Flow
-61.2M
↑ 95.91%
Financing Cash Flow
-2.6M
↓ 111.8%
FY21Y/Y Change
Operating Cash Flow
173.4M
↑ 113.42%
Investing Cash Flow
-37.0M
↓ 39.57%
Financing Cash Flow
-125.9M
↑ 4811.68%
FY22Y/Y Change
Operating Cash Flow
50.6M
↓ 70.82%
Investing Cash Flow
-4.3M
↓ 88.27%
Financing Cash Flow
-48.1M
↓ 61.75%
Q4 FY22Q/Q Change
Operating Cash Flow
4.5M
↓ 161.71%
Investing Cash Flow
7.9M
↓ 233.77%
Financing Cash Flow
-14.8M
↓ 766.63%
Q1 FY23Q/Q Change
Operating Cash Flow
1.1M
↓ 76.65%
Investing Cash Flow
-5.4M
↓ 168.73%
Financing Cash Flow
2.9M
↓ 119.97%
Q2 FY23Q/Q Change
Operating Cash Flow
12.3K
↓ 98.83%
Investing Cash Flow
-3.1M
↓ 43.32%
Financing Cash Flow
3.0M
↑ 1.02%

Technicals Summary

Sell

Neutral

Buy

Nutex Health Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nutex Health Inc
Nutex Health Inc
21.74%
-75.78%
-88.84%
-99.89%
-99.89%
Solventum Corp
Solventum Corp
4.3%
-20.98%
-20.98%
-20.98%
-20.98%
Veeva Systems Inc.
Veeva Systems Inc.
-0.88%
-12.48%
-8.24%
-43.42%
8.57%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
1.6%
7.77%
-2.65%
32.98%
32.98%
Healthequity Inc
Healthequity Inc
-12.27%
-2.08%
16.94%
-3.03%
-8.24%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nutex Health Inc
Nutex Health Inc
1.12
1.12
NA
-1.87
-0.39
0.01
NA
12.68
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
53.22
53.22
1.35
4.76
0.13
0.06
NA
30.25
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
23.38
23.38
20.11
4.27
0.22
0.06
0.0
16.23
Healthequity Inc
Healthequity Inc
84.29
84.29
2.29
2.19
0.04
0.03
NA
24.11
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nutex Health Inc
Nutex Health Inc
Buy
$33.4M
-99.89%
1.12
-15.85%
Solventum Corp
Solventum Corp
Hold
$10.8B
-20.98%
NA
15.73%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$29.2B
8.57%
53.22
22.34%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$36.7B
32.98%
23.38
8.05%
Healthequity Inc
Healthequity Inc
Buy
$6.7B
-8.24%
84.29
7.71%

Insights on Nutex Health Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 69.66M → 67.45M (in $), with an average decrease of 3.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -31.61M → -364.07K (in $), with an average increase of 8584.5% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 16.9% return, outperforming this stock by 105.7%

Institutional Holdings

  • Highbridge Capital Management, LLC

    4.51%
  • Vanguard Group Inc

    1.74%
  • ONE + ONE WEALTH MANAGEMENT, LLC

    0.71%
  • BlackRock Inc

    0.62%
  • Geode Capital Management, LLC

    0.59%
  • BB&T Corp.

    0.59%

Company Information

nutex health is a consortium of licensed 24/7 free standing emergency centers. our philosophy is simple: bring concierge level, high quality emergency care to the local community. we build the best teams of local doctors and nursing staff and provide the best medical care for our patients in a convenient and friendly atmosphere. currently in austin, beaumont, dallas, eagle pass, kyle, laredo, lufkin, richmond, san angelo, texarkana, & victoria.

Organization
Nutex Health Inc
Employees
800
CEO
Dr. Thomas T. Vo M.B.A., M.D.
Industry
Healthcare

FAQs